Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
Department of Community Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
PLoS One. 2021 Mar 26;16(3):e0248401. doi: 10.1371/journal.pone.0248401. eCollection 2021.
Collection and storage of biospecimens and data for biobanking raise many ethical concerns. Stakeholders' opinions about these ethical issues are important since they can help in the development of ethical guidelines to govern biobanking activities. Physicians are among the important stakeholders since they contact potential participants and could be biobank users. The goal of this study is to evaluate the perceptions and attitude of Egyptian physicians towards ethical issues in biobanking.
A cross-sectional online survey was designed and distributed with the target group between November 2019 and January 2020.
The questionnaire was completed by 223 physicians. While 65.5% reported hearing the term "Biobanking" before, 45.7% knew that there are biobanks in Egypt. Participants had a general positive attitude towards the value of biobanks in research. About 73% agreed that biobanks can share biospecimens with international research organizations, but only 42.6% supported collaboration with pharmaceutical companies, and 44% agreed to the use of user fees by biobanks. About 48% supported the use of broad consent in biobanks, and 73.1% believed that donors of biospecimens should be informed about results of research performed on their biospecimens.
Although many Egyptian physicians heard about biobanking, they had limited knowledge about the existence of biobanks in Egypt. They had concerns about commercialization, use of broad consent and user fees. A knowledge gap exists among these stakeholders, which should be covered by different educational activities. Community discussions should start to reach consensus about the issues of commercialization and return of research results.
生物样本和数据的收集和存储引起了许多伦理问题。利益相关者对这些伦理问题的看法很重要,因为它们有助于制定规范生物库活动的伦理准则。医生是重要的利益相关者之一,因为他们接触潜在的参与者,并且可能是生物库的使用者。本研究的目的是评估埃及医生对生物库伦理问题的看法和态度。
设计了一项横断面在线调查,并于 2019 年 11 月至 2020 年 1 月期间在目标人群中进行了分发。
共有 223 名医生完成了问卷。虽然 65.5%的人之前听说过“生物库”一词,但 45.7%的人知道埃及有生物库。参与者对生物库在研究中的价值持普遍积极的态度。约 73%的人同意生物库可以与国际研究组织共享生物样本,但只有 42.6%的人支持与制药公司合作,44%的人同意生物库收取用户费用。约 48%的人支持在生物库中使用广泛同意,73.1%的人认为生物样本的捐赠者应该被告知对其生物样本进行的研究结果。
尽管许多埃及医生听说过生物库,但他们对埃及生物库的存在知之甚少。他们对商业化、广泛同意和用户费用的使用表示担忧。这些利益相关者之间存在知识差距,应该通过不同的教育活动来填补。应该开始进行社区讨论,就商业化和研究结果的回报问题达成共识。